Related Experiment Video
Updated: Aug 9, 2026

08:32
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
A global approach to tumor immunology
Ena Wang1, Monica C Panelli, Vladia Monsurró
1Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20892, USA. EWang@maill.cc.nih.gov
Cellular & Molecular Immunology
|October 18, 2005
Summary
Tumor immunology is complex, requiring discovery-driven research for real-time tumor/host interaction studies. Understanding inflammation
Area of Science:
- Tumor Immunology
- Cancer Biology
- Inflammation Research
Background:
- Human tumor immunology is complex, challenging hypothesis-driven research.
- Tumor-immune cell interactions are intricate, necessitating novel study approaches.
- Immune cell infiltration in tumors can have dual roles in cancer progression.
Purpose of the Study:
- To propose a discovery-driven approach for studying tumor immunology.
- To investigate the role of tumor cell phenotype in driving tumor microenvironment inflammation.
- To explore the complex interplay between tumor cells and immune cells.
Main Methods:
- High-throughput, discovery-driven approach for real-time tumor/host interaction analysis.
- Review of recent experimental work and available literature.
- Focus on functional genomic studies and cell-to-cell interactions.
Main Results:
- Current understanding lacks a single, solid hypothesis for tumor immunology.
- Tumor-immune cell dynamics are too complex for purely hypothesis-driven methods.
- Tumor cell phenotype is hypothesized to be the primary driver of tumor site inflammation.
Conclusions:
- A discovery-driven, real-time approach is essential for studying tumor immunology.
- Inflammation at the tumor site is likely induced by tumor cell phenotype.
- Tumor cells and immune cells exist in a complex, interdependent balance.
Related Concept Videos
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

